Skip to main content

Table 4 Economic consequences of less frequent CD4 monitoring in Italy

From: Is it still worthwhile to perform quarterly cd4+ t lymphocyte cell counts on hiv-1 infected stable patients?

  Column A
CD4 2 times/year 		Column B
CD4 2.7 times/year 		Column C
CD4 3 times/year
Total cost € 594.428 € 799.506 € 891.642
Cost saving (1st scenario) € 297.214 € 502.292 € 594.428
Cost saving (2nd scenario) € 198.143 € 403.220 € 495.357
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us